| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/21645515.2015.1081727 |
| P8608 | Fatcat ID | release_k7rip3chjzaf3gnmciwh2q5ohm |
| P932 | PMC publication ID | 4685673 |
| P698 | PubMed publication ID | 26308501 |
| P2093 | author name string | Yu Wang | |
| Wenbin Ma | |||
| Qiangyi Zhou | |||
| P2860 | cites work | Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: a phase II, single-arm trial | Q37492175 |
| EGFRvIII mCAR-modified T-cell therapy cures mice with established intracerebral glioma and generates host immunity against tumor-antigen loss. | Q37618652 | ||
| Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas | Q37658308 | ||
| Rindopepimut: an evidence-based review of its therapeutic potential in the treatment of EGFRvIII-positive glioblastoma | Q38051323 | ||
| Heat-shock proteins as dendritic cell-targeting vaccines--getting warmer. | Q38095583 | ||
| A new hope in immunotherapy for malignant gliomas: adoptive T cell transfer therapy | Q38227889 | ||
| Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapy | Q45036488 | ||
| Immunotherapy for high-grade glioma | Q45866091 | ||
| A population-based description of glioblastoma multiforme in Los Angeles County, 1974-1999. | Q46133533 | ||
| Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma | Q48616807 | ||
| Ex vivo functional analysis, expansion and adoptive transfer of cytomegalovirus-specific T-cells in patients with glioblastoma multiforme. | Q55462188 | ||
| Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients. | Q55471514 | ||
| T-lymphocyte entry into the central nervous system | Q70156307 | ||
| Current vaccine trials in glioblastoma: a review | Q26828965 | ||
| Sipuleucel-T immunotherapy for castration-resistant prostate cancer | Q27860648 | ||
| Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma | Q27860910 | ||
| Improved Survival with Ipilimumab in Patients with Metastatic Melanoma | Q27861062 | ||
| Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial | Q29547224 | ||
| Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia | Q29617590 | ||
| Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates | Q29620051 | ||
| Antibody-based immunotherapy for malignant glioma | Q34120472 | ||
| Overview of cellular immunotherapy for patients with glioblastoma. | Q34189694 | ||
| Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity | Q35870655 | ||
| CTLA-4 blockade with ipilimumab: long-term follow-up of 177 patients with metastatic melanoma | Q35871798 | ||
| Trial Watch: Adoptive cell transfer immunotherapy | Q36057432 | ||
| Bcl-2 overexpression enhances tumor-specific T-cell survival | Q36327125 | ||
| Transduction of tumor-specific T cells with CXCR2 chemokine receptor improves migration to tumor and antitumor immune responses | Q36333963 | ||
| Basic concepts of immunology and neuroimmunology | Q36525975 | ||
| Microglia: gatekeepers of central nervous system immunology. | Q37333298 | ||
| Intracerebral delivery of a third generation EGFRvIII-specific chimeric antigen receptor is efficacious against human glioma. | Q37402375 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | glioblastoma | Q282142 |
| immunotherapy | Q1427096 | ||
| P304 | page(s) | 2654-8 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Human Vaccines & Immunotherapeutics | Q21072749 |
| P1476 | title | The progress of immunotherapy for glioblastoma | |
| P478 | volume | 11 |
Search more.